Characterization of the inhibitor binding site in mitochondrial NADH-ubiquinone oxidoreductase by photoaffinity labeling using a quinazoline-type inhibitor

Masatoshi Murai, Koji Sekiguchi, Takaaki Nishioka, Hideto Miyoshi

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

The diverse inhibitors of bovine heart mitochondrial complex I (NADH-ubiquinone oxidoreductase) are believed to share a common large binding domain with partially overlapping sites, though it remains unclear how these binding sites relate to each other. To obtain new insight into the inhibitor binding domain in complex I, we synthesized a photoreactive azidoquinazoline {[125I]-6-azido-4-(4-iodophenethylamino)quinazoline, [ 125I]AzQ}, in which a photolabile azido group was introduced into the toxophoric quinazoline ring to allow specific cross-linking, and carried out a photoaffinity labeling study using bovine heart submitochondrial particles. Analysis of the photo-cross-linked proteins by peptide mass fingerprinting and immunoblotting revealed that [125I]AzQ specifically binds to the 49 kDa and ND1 subunits with a frequency of ∼4:1. The cross-linking was completely blocked by excess amounts of other inhibitors such as acetogenin and fenpyroximate. Considerable cross-linking was also detected in the ADP/ATP carrier and 3-hydroxybutyrate dehydrogenase, though it was not associated with dysfunction of the two proteins. The partial proteolysis of the [ 125I]AzQ-labeled 49 kDa subunit by V8-protease and N-terminal sequencing of the resulting peptides revealed that the amino acid residue cross-linked by [125I]AzQ is within the sequence region Thr25-Glu143 (118 amino acids). Furthermore, examination of fragment patterns generated by exhaustive digestion of the [125I]AzQ-labeled 49 kDa subunit by V8-protease, lysylendopeptidase, or trypsin strongly suggested that the cross-linked residue is located within the region Asp41-Arg63 (23 amino acids). The present study has revealed, for the first time, the inhibitor binding site in complex I at the sub-subunit level.

Original languageEnglish
Pages (from-to)688-698
Number of pages11
JournalBiochemistry
Volume48
Issue number4
DOIs
Publication statusPublished - 2009 Feb 3
Externally publishedYes

Fingerprint

Quinazolines
Electron Transport Complex I
Labeling
Binding Sites
Amino Acids
Acetogenins
Hydroxybutyrate Dehydrogenase
ATP Translocases Mitochondrial ADP
Submitochondrial Particles
Proteolysis
Peptides
Peptide Mapping
Immunoblotting
Trypsin
Digestion
Proteins

ASJC Scopus subject areas

  • Biochemistry

Cite this

Characterization of the inhibitor binding site in mitochondrial NADH-ubiquinone oxidoreductase by photoaffinity labeling using a quinazoline-type inhibitor. / Murai, Masatoshi; Sekiguchi, Koji; Nishioka, Takaaki; Miyoshi, Hideto.

In: Biochemistry, Vol. 48, No. 4, 03.02.2009, p. 688-698.

Research output: Contribution to journalArticle

Murai, Masatoshi ; Sekiguchi, Koji ; Nishioka, Takaaki ; Miyoshi, Hideto. / Characterization of the inhibitor binding site in mitochondrial NADH-ubiquinone oxidoreductase by photoaffinity labeling using a quinazoline-type inhibitor. In: Biochemistry. 2009 ; Vol. 48, No. 4. pp. 688-698.
@article{a0ee155a96b34a3087b573c2ae33c2e8,
title = "Characterization of the inhibitor binding site in mitochondrial NADH-ubiquinone oxidoreductase by photoaffinity labeling using a quinazoline-type inhibitor",
abstract = "The diverse inhibitors of bovine heart mitochondrial complex I (NADH-ubiquinone oxidoreductase) are believed to share a common large binding domain with partially overlapping sites, though it remains unclear how these binding sites relate to each other. To obtain new insight into the inhibitor binding domain in complex I, we synthesized a photoreactive azidoquinazoline {[125I]-6-azido-4-(4-iodophenethylamino)quinazoline, [ 125I]AzQ}, in which a photolabile azido group was introduced into the toxophoric quinazoline ring to allow specific cross-linking, and carried out a photoaffinity labeling study using bovine heart submitochondrial particles. Analysis of the photo-cross-linked proteins by peptide mass fingerprinting and immunoblotting revealed that [125I]AzQ specifically binds to the 49 kDa and ND1 subunits with a frequency of ∼4:1. The cross-linking was completely blocked by excess amounts of other inhibitors such as acetogenin and fenpyroximate. Considerable cross-linking was also detected in the ADP/ATP carrier and 3-hydroxybutyrate dehydrogenase, though it was not associated with dysfunction of the two proteins. The partial proteolysis of the [ 125I]AzQ-labeled 49 kDa subunit by V8-protease and N-terminal sequencing of the resulting peptides revealed that the amino acid residue cross-linked by [125I]AzQ is within the sequence region Thr25-Glu143 (118 amino acids). Furthermore, examination of fragment patterns generated by exhaustive digestion of the [125I]AzQ-labeled 49 kDa subunit by V8-protease, lysylendopeptidase, or trypsin strongly suggested that the cross-linked residue is located within the region Asp41-Arg63 (23 amino acids). The present study has revealed, for the first time, the inhibitor binding site in complex I at the sub-subunit level.",
author = "Masatoshi Murai and Koji Sekiguchi and Takaaki Nishioka and Hideto Miyoshi",
year = "2009",
month = "2",
day = "3",
doi = "10.1021/bi8019977",
language = "English",
volume = "48",
pages = "688--698",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "4",

}

TY - JOUR

T1 - Characterization of the inhibitor binding site in mitochondrial NADH-ubiquinone oxidoreductase by photoaffinity labeling using a quinazoline-type inhibitor

AU - Murai, Masatoshi

AU - Sekiguchi, Koji

AU - Nishioka, Takaaki

AU - Miyoshi, Hideto

PY - 2009/2/3

Y1 - 2009/2/3

N2 - The diverse inhibitors of bovine heart mitochondrial complex I (NADH-ubiquinone oxidoreductase) are believed to share a common large binding domain with partially overlapping sites, though it remains unclear how these binding sites relate to each other. To obtain new insight into the inhibitor binding domain in complex I, we synthesized a photoreactive azidoquinazoline {[125I]-6-azido-4-(4-iodophenethylamino)quinazoline, [ 125I]AzQ}, in which a photolabile azido group was introduced into the toxophoric quinazoline ring to allow specific cross-linking, and carried out a photoaffinity labeling study using bovine heart submitochondrial particles. Analysis of the photo-cross-linked proteins by peptide mass fingerprinting and immunoblotting revealed that [125I]AzQ specifically binds to the 49 kDa and ND1 subunits with a frequency of ∼4:1. The cross-linking was completely blocked by excess amounts of other inhibitors such as acetogenin and fenpyroximate. Considerable cross-linking was also detected in the ADP/ATP carrier and 3-hydroxybutyrate dehydrogenase, though it was not associated with dysfunction of the two proteins. The partial proteolysis of the [ 125I]AzQ-labeled 49 kDa subunit by V8-protease and N-terminal sequencing of the resulting peptides revealed that the amino acid residue cross-linked by [125I]AzQ is within the sequence region Thr25-Glu143 (118 amino acids). Furthermore, examination of fragment patterns generated by exhaustive digestion of the [125I]AzQ-labeled 49 kDa subunit by V8-protease, lysylendopeptidase, or trypsin strongly suggested that the cross-linked residue is located within the region Asp41-Arg63 (23 amino acids). The present study has revealed, for the first time, the inhibitor binding site in complex I at the sub-subunit level.

AB - The diverse inhibitors of bovine heart mitochondrial complex I (NADH-ubiquinone oxidoreductase) are believed to share a common large binding domain with partially overlapping sites, though it remains unclear how these binding sites relate to each other. To obtain new insight into the inhibitor binding domain in complex I, we synthesized a photoreactive azidoquinazoline {[125I]-6-azido-4-(4-iodophenethylamino)quinazoline, [ 125I]AzQ}, in which a photolabile azido group was introduced into the toxophoric quinazoline ring to allow specific cross-linking, and carried out a photoaffinity labeling study using bovine heart submitochondrial particles. Analysis of the photo-cross-linked proteins by peptide mass fingerprinting and immunoblotting revealed that [125I]AzQ specifically binds to the 49 kDa and ND1 subunits with a frequency of ∼4:1. The cross-linking was completely blocked by excess amounts of other inhibitors such as acetogenin and fenpyroximate. Considerable cross-linking was also detected in the ADP/ATP carrier and 3-hydroxybutyrate dehydrogenase, though it was not associated with dysfunction of the two proteins. The partial proteolysis of the [ 125I]AzQ-labeled 49 kDa subunit by V8-protease and N-terminal sequencing of the resulting peptides revealed that the amino acid residue cross-linked by [125I]AzQ is within the sequence region Thr25-Glu143 (118 amino acids). Furthermore, examination of fragment patterns generated by exhaustive digestion of the [125I]AzQ-labeled 49 kDa subunit by V8-protease, lysylendopeptidase, or trypsin strongly suggested that the cross-linked residue is located within the region Asp41-Arg63 (23 amino acids). The present study has revealed, for the first time, the inhibitor binding site in complex I at the sub-subunit level.

UR - http://www.scopus.com/inward/record.url?scp=60749121178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60749121178&partnerID=8YFLogxK

U2 - 10.1021/bi8019977

DO - 10.1021/bi8019977

M3 - Article

C2 - 19128036

AN - SCOPUS:60749121178

VL - 48

SP - 688

EP - 698

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 4

ER -